Over the years, understanding of the biological background of c-KIT in renal cell carcinoma has been gained, particularly the overexpression of c-Kit, which has been observed to play a role in tumor growth and progression, making it an appealing therapeutic target for kidney cancer therapeutic development [53,54,55]. This evidence concerns the gene KIT and renal cell carcinoma.